Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1

Molecular Cell

Volumn 17, Issue 4, 2005, Pages 491-502

  Li, Yong ^a   Choi, Mihwa ^b   Cavey, Greg ^a   Daugherty, Jennifer ^a   Suino, Kelly ^a   Kovach, Amanda ^a   Bingham, Nathan C ^b   Kliewer, Steven A ^b   Xu, H Eric ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PHOSPHOLIPID; STEROIDOGENIC FACTOR 1;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; HUMAN; HUMAN CELL; HYDROGEN BOND; MUTATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION;

EID: 13944276441     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2005.02.002     Document Type: Article

References (43)

1. Bakke M., Zhao L., Hanley N.A., Parker K.L. SF-1. a critical mediator of steroidogenesis Mol. Cell. Endocrinol. 171:2001;5-7
2. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell. 110:2002;93-105
3. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
4. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology. opening the X-files Science. 294:2001;1866-1870
5. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356
6. Desclozeaux M., Krylova I.N., Horn F., Fletterick R.J., Ingraham H.A. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol. Cell. Biol. 22:2002;7193-7203
7. Dhe-Paganon S., Duda K., Iwamoto M., Chi Y.I., Shoelson S.E. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277:2002;37973-37976
8. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5:2000;545-555. a
9. Gampe R.T. Jr., Montana V.G., Lambert M.H., Wisely G.B., Milburn M.V., Xu H.E. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 14:2000;2229-2241. b
10. Hammer G.D., Krylova I., Zhang Y., Darimont B.D., Simpson K., Weigel N.L., Ingraham H.A. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment. integration of hormone signaling in reproduction and stress Mol. Cell. 3:1999;521-526
11. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 402:1999;93-96
12. Hunt A.N., Clark G.T., Attard G.S., Postle A.D. Highly saturated endonuclear phosphatidylcholine is synthesized in situ and colocated with CDP-choline pathway enzymes. J. Biol. Chem. 276:2001;8492-8499
13. Ingraham H.A., Lala D.S., Ikeda Y., Luo X., Shen W.H., Nachtigal M.W., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8:1994;2302-2312
14. Irvine R.F. Nuclear lipid signalling. Nat. Rev. Mol. Cell Biol. 4:2003;349-360
15. Ito M., Yu R., Jameson J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1997;1476-1483
16. Kleywegt, G.J., and Jones, T.A. (1994). Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Cryst D, 178-185.
17. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors. shifting endocrinology into reverse Science. 284:1999;757-760
18. Lala D.S., Syka P.M., Lazarchik S.B., Mangelsdorf D.J., Parker K.L., Heyman R.A. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc. Natl. Acad. Sci. USA. 94:1997;4895-4900
19. Li Y., Lambert M.H., Xu H.E. Activation of nuclear receptors. a perspective from structural genomics Structure (Camb). 11:2003;741-746
20. Loo J.A. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom. Rev. 16:1997;1-23
21. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 77:1994;481-490
22. Mellon S.H., Bair S.R. 25-Hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1). Endocrinology. 139:1998;3026-3029
23. Nachtigal M.W., Hirokawa Y., Enyeart-VanHouten D.L., Flanagan J.N., Hammer G.D., Ingraham H.A. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:1998;445-454
24. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., Krishna V., Chatterjee K., Evans R.M., Schwabe J.W. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:1999;3209-3216
25. Navaza J., Gover S., Wolf W. AMoRe. A new package for molecular replacement Dodson E.J. Molecular Replacement. Proceedings of the CCP4 Study Weekend:1992;87-90 SERC, Daresbury, UK
26. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-gamma. Nature. 395:1998;137-143
27. Otwinowski Z., Minor W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326
28. Parker K.L., Rice D.A., Lala D.S., Ikeda Y., Luo X., Wong M., Bakke M., Zhao L., Frigeri C., Hanley N.A., et al. Steroidogenic factor 1. an essential mediator of endocrine development Recent Prog. Horm. Res. 57:2002;19-36
29. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:1999;3198-3208
30. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all- trans retinoic acid. Nature. 378:1995;681-689
31. Rostom A.A., Robinson C.V. Disassembly of intact multiprotein complexes in the gas phase. Curr. Opin. Struct. Biol. 9:1999;135-141
32. Sablin E.P., Krylova I.N., Fletterick R.J., Ingraham H.A. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol. Cell. 11:2003;1575-1585
33. Sadovsky Y., Dorn C. Function of steroidogenic factor 1 during development and differentiation of the reproductive system. Rev. Reprod. 5:2000;136-142
34. Shen W.H., Moore C.C., Ikeda Y., Parker K.L., Ingraham H.A. Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene. a link to the sex determination cascade Cell. 77:1994;651-661
35. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937
36. Suino K., Peng L., Reynolds R., Li Y., Cha J.Y., Repa J.J., Kliewer S.A., Xu H.E. The nuclear xenobiotic receptor CAR; structural determinants of constitutive activation and heterodimerization. Mol. Cell. 16:2004;893-905
37. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697
38. Wilson T.E., Fahrner T.J., Milbrandt J. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 13:1993;5794-5804
39. Wisely G.B., Miller A.B., Davis R.G., Thornquest A.D. Jr., Johnson R., Spitzer T., Sefler A., Shearer B., Moore J.T., Willson T.M., Williams S.P. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure (Camb). 10:2002;1225-1234
40. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., Sternbach D.D., Lehmann J.M., Wisely G.B., Willson T.M., et al. Molecular recognition of fatty acids by peroxisome proliferator- activated receptors. Mol. Cell. 3:1999;397-403
41. Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B., Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T. Jr., McKee D.D., et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 98:2001;13919-13924
42. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T., et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 415:2002;813-817
43. Zhou G., Cummings R., Li Y., Mitra S., Wilkinson H.A., Elbrecht A., Hermes J.D., Schaeffer J.M., Smith R.G., Moller D.E. Nuclear receptors have distinct affinities for coactivators. characterization by fluorescence resonance energy transfer Mol. Endocrinol. 12:1998;1594-1604